Innover et diriger en 2030

by Guillaume Villon de Benveniste

  • Quels seront les vecteurs de croissance de l’économie mondiale d’ici 2030 ?
  • Pourquoi l’innovation est-elle déterminante pour être compétitif ?
  • Comment allouer les ressources humaines et financières de l’entreprise de la façon la plus pertinante ?

Autant de pistes qui seront explorées par Guillaume Villon de Benveniste le jeudi 16 mars prochain à 18h30, à LEspace Dirigeants : venez nombreux ! 

♦♦♦♦♦♦♦

Quelques mots sur notre speaker :

Guillaume is helping Fortune 500 accounts succeed at innovation & digital transformation, by developing a novel approach to creating innovations that people buy. He’s working with multiple global companies on innovation issues, including Orange, Pfizer, Merck, Danone, Air Liquide, Vodafone, Microsoft and Schneider.

He has helped Inova, an innovation software company, improve its product portfolio by applying the “jobs-to-be done” innovation approach, resulting in new client acquisitions.

He has worked with Alcimed, a Paris-based consultancy focused on healthcare, to create an office in the NYC/Princeton area. There, he helped leading Pharmaceutical companies, including Pfizer and Merck move from a molecule-based business model to a solutions business model. He has sold the largest innovation consulting project in healthcare Alcimed ever sold in its 17 year old history.

Before Alcimed, he has helped leading software companies, such as Microsoft and Dassault Systèmes, with their innovation capabilities.

Guillaume has received his Master’s Degree in Philosophy at Sorbonne University in Paris and his MBA (“Diplôme Grande Ecole”) from ESSEC, a leading business school based out of Paris. A Virginian by birth and Frenchmen by education, Guillaume takes part in the transatlantic dialog on innovation.

Vous n’avez pas reçu l’invitation mais souhaitez vous inscrire ? Remplissez les champs ci-dessous, nous sommes à votre écoute !

L’ACTU DE LED

VOIR LE BLOG